Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Death Differ ; 20(3): 503-14, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23175188

ABSTRACT

Myc oncoproteins are commonly upregulated in human cancers of different organ origins, stabilized by Aurora A, degraded through ubiquitin-proteasome pathway-mediated proteolysis, and exert oncogenic effects by modulating gene and protein expression. Histone deacetylases are emerging as targets for cancer therapy. Here we demonstrated that the class III histone deacetylase SIRT2 was upregulated by N-Myc in neuroblastoma cells and by c-Myc in pancreatic cancer cells, and that SIRT2 enhanced N-Myc and c-Myc protein stability and promoted cancer cell proliferation. Affymetrix gene array studies revealed that the gene most significantly repressed by SIRT2 was the ubiquitin-protein ligase NEDD4. Consistent with this finding, SIRT2 repressed NEDD4 gene expression by directly binding to the NEDD4 gene core promoter and deacetylating histone H4 lysine 16. Importantly, NEDD4 directly bound to Myc oncoproteins and targeted Myc oncoproteins for ubiquitination and degradation, and small-molecule SIRT2 inhibitors reactivated NEDD4 gene expression, reduced N-Myc and c-Myc protein expression, and suppressed neuroblastoma and pancreatic cancer cell proliferation. Additionally, SIRT2 upregulated and small-molecule SIRT2 inhibitors decreased Aurora A expression. Our data reveal a novel pathway critical for Myc oncoprotein stability, and provide important evidences for potential application of SIRT2 inhibitors for the prevention and therapy of Myc-induced malignancies.


Subject(s)
Proto-Oncogene Proteins c-myc/metabolism , Sirtuin 2/metabolism , Aurora Kinases , Cell Line, Tumor , Cell Proliferation , Endosomal Sorting Complexes Required for Transport , Gene Expression , Humans , Naphthols/pharmacology , Nedd4 Ubiquitin Protein Ligases , Phenylpropionates/pharmacology , Phosphorylation , Protein Binding , Protein Serine-Threonine Kinases/genetics , Protein Serine-Threonine Kinases/metabolism , Protein Stability , Proto-Oncogene Proteins c-myc/antagonists & inhibitors , Proto-Oncogene Proteins c-myc/genetics , RNA Interference , RNA, Messenger/metabolism , RNA, Small Interfering/metabolism , Sirtuin 2/antagonists & inhibitors , Sirtuin 2/genetics , Ubiquitin-Protein Ligases , Ubiquitination , Up-Regulation/drug effects
2.
Oncogene ; 29(46): 6172-83, 2010 Nov 18.
Article in English | MEDLINE | ID: mdl-20729920

ABSTRACT

The family of tripartite-motif (TRIM) proteins are involved in diverse cellular processes, but are often characterized by critical protein-protein interactions necessary for their function. TRIM16 is induced in different cancer types, when the cancer cell is forced to proceed down a differentiation pathway. We have identified TRIM16 as a DNA-binding protein with histone acetylase activity, which is required for the retinoic acid receptor ß(2) transcriptional response in retinoid-treated cancer cells. In this study, we show that overexpressed TRIM16 reduced neuroblastoma cell growth, enhanced retinoid-induced differentiation and reduced tumourigenicity in vivo. TRIM16 was only expressed in the differentiated ganglion cell component of primary human neuroblastoma tumour tissues. TRIM16 bound directly to cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. TRIM16 reduced cell motility and this required downregulation of vimentin. Retinoid treatment and enforced overexpression caused TRIM16 to translocate to the nucleus, and bind to and downregulate nuclear E2F1, required for cell replication. This study, for the first time, demonstrates that TRIM16 acts as a tumour suppressor, affecting neuritic differentiation, cell migration and replication through interactions with cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.


Subject(s)
DNA-Binding Proteins/physiology , E2F1 Transcription Factor/antagonists & inhibitors , Neuroblastoma/pathology , Transcription Factors/physiology , Tumor Suppressor Proteins/physiology , Vimentin/antagonists & inhibitors , Animals , Cell Differentiation , Cell Movement , Cell Nucleus/metabolism , Cytoplasm/metabolism , E2F1 Transcription Factor/metabolism , Female , Humans , Mice , Mice, Inbred BALB C , Tripartite Motif Proteins , Ubiquitin-Protein Ligases , Vimentin/physiology
3.
Oncogene ; 28(13): 1605-15, 2009 Apr 02.
Article in English | MEDLINE | ID: mdl-19234491

ABSTRACT

Medulloblastoma tumorigenesis caused by inactivating mutations in the PATCHED1 (PTCH1) gene is initiated by persistently activated Sonic Hedgehog (Shh) signaling in granule neuron precursors (GNPs) during the late stages of cerebellar development. Both normal cerebellar development and Shh-driven medulloblastoma tumorigenesis require N-Myc expression. However, the mechanisms by which N-Myc affects the stages of medulloblastoma initiation and progression are unknown. Here we used a mouse model of Ptch1 heterozygosity and medulloblastoma to show that increased N-Myc expression characterized the earliest selection of focal GNP hyperplasia destined for later tumor progression. Step-wise loss of Ptch1 expression, from tumor initiation to progression, led to incremental increases in N-Myc protein, rather than mRNA, expression. Increased N-Myc resulted in enhanced proliferation and death resistance of perinatal GNPs at tumor initiation. Sequential N-Myc protein phosphorylation at serine-62 and serine-62/threonine-58 characterized the early and late stages of medulloblastoma tumorigenesis, respectively. Shh pathway activation led to increased Myc protein stability and reduced expression of key regulatory factors. Taken together our data identify N-Myc protein stability as the result of loss of Ptch1, which distinguishes normal cerebellar development from medulloblastoma tumorigenesis.


Subject(s)
Cerebellar Neoplasms/genetics , Cerebellar Neoplasms/pathology , Medulloblastoma/genetics , Medulloblastoma/pathology , Proto-Oncogene Proteins c-myc/metabolism , Receptors, Cell Surface/genetics , Animals , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cerebellar Neoplasms/metabolism , Disease Progression , Gene Deletion , Gene Expression Regulation, Neoplastic , Hedgehog Proteins/metabolism , Medulloblastoma/metabolism , Mice , Mice, Transgenic , Models, Biological , NIH 3T3 Cells , Patched Receptors , Patched-1 Receptor , Protein Stability , Proto-Oncogene Proteins c-myc/genetics , Receptors, Cell Surface/physiology , Signal Transduction/genetics
4.
Br J Cancer ; 100(1): 96-105, 2009 Jan 13.
Article in English | MEDLINE | ID: mdl-19127267

ABSTRACT

Increased retinoic acid receptor beta (RARbeta(2)) gene expression is a hallmark of cancer cell responsiveness to retinoid anticancer effects. Moreover, low basal or induced RARbeta(2) expression is a common feature of many human cancers, suggesting that RARbeta(2) may act as a tumour suppressor gene in the absence of supplemented retinoid. We have previously shown that low RARbeta(2) expression is a feature of advanced neuroblastoma. Here, we demonstrate that the ABC domain of the RARbeta(2) protein alone was sufficient for the growth inhibitory effects of RARbeta(2) on neuroblastoma cells. ATP7A, the copper efflux pump, is a retinoid-responsive gene, was upregulated by ectopic overexpression of RARbeta(2). The ectopic overexpression of the RARbeta(2) ABC domain was sufficient to induce ATP7A expression, whereas, RARbeta(2) siRNA blocked the induction of ATP7A expression in retinoid-treated neuroblastoma cells. Forced downregulation of ATP7A reduced copper efflux and increased viability of retinoid-treated neuroblastoma cells. Copper supplementation enhanced cell growth and reduced retinoid-responsiveness, whereas copper chelation reduced the viability and proliferative capacity. Taken together, our data demonstrates ATP7A expression is regulated by retinoic acid receptor beta and it has effects on intracellular copper levels, revealing a link between the anticancer action of retinoids and copper metabolism.


Subject(s)
Adenosine Triphosphatases/physiology , Cation Transport Proteins/physiology , Neuroblastoma/drug therapy , Receptors, Retinoic Acid/physiology , Adenosine Triphosphatases/genetics , Cation Transport Proteins/genetics , Cell Line, Tumor , Cell Proliferation , Copper/metabolism , Copper-Transporting ATPases , Gene Expression Regulation, Neoplastic , Humans , Neuroblastoma/pathology , Retinoids/pharmacology , Retinoids/therapeutic use
5.
Int Immunopharmacol ; 6(6): 957-61, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16644481

ABSTRACT

Infection with Mycobacterium bovis is a significant human and animal health problem in many parts of the world. The first stage of pulmonary tuberculosis occurs after inhalation of the bacilli into an alveolus where they are ingested by resident macrophages. DNA microarray analysis was used to detect genes expressed in bovine lung alveolar macrophages infected with two isogenic strains of M. bovis, a virulent strain, ATCC35723 and an attenuated strain, WAg520 derived from ATCC35723. Chemokines, interleukin-8 and monocyte chemotactic protein 1, were more strongly expressed in ATCC35723-infected macrophages compared to WAg520-infected macrophages. Conversely, a group of genes, including fibrinogen-like protein 2 and legumain, were expressed at a higher level in macrophages infected with WAg520 compared to ATCC35723. Quantitative real-time PCR of a selected group of these differentially expressed genes confirmed enhanced levels of IL-8 mRNA in ATCC35723-infected macrophages compared to WAg520-infected macrophages. Microarray analysis of gene expression in macrophages infected with attenuated isogenic strains of M. bovis may identify key genes involved in early and protective immune responses to tuberculosis.


Subject(s)
Gene Expression Profiling , Macrophages, Alveolar/metabolism , Mycobacterium bovis/growth & development , Animals , Cattle , Cells, Cultured , Chemokine CCL2/genetics , Cysteine Endopeptidases/genetics , Gene Expression/genetics , Interleukin-8/genetics , Macrophages, Alveolar/cytology , Macrophages, Alveolar/microbiology , Mycobacterium bovis/pathogenicity , Oligonucleotide Array Sequence Analysis , Protein Serine-Threonine Kinases/genetics , Virulence
SELECTION OF CITATIONS
SEARCH DETAIL
...